In this article

The alanmeds.com site now presents Alan Health, while many shoppers still search for Alan Meds. Its current semaglutide promotion uses a two-month prepaid offer, making the regular refill price and total payment important comparison points.

This guide covers weight-management alternatives rather than Alan’s other treatment categories. It separates the introductory offer from ongoing care and avoids assuming that a different route or formulation has the same evidence.

THE SHORT ANSWER

Compare the full two-month commitment, the nonpromotional renewal, and the exact proposed formulation. CoreAge Rx holds the first sponsored position; that does not establish that it best meets every criterion.

What to know first

  • Compare the full two-month commitment, the nonpromotional renewal, and the exact proposed formulation.
  • CoreAge Rx is the first listing through a disclosed commercial arrangement.
  • Confirm the proposed product, care arrangement, and complete written payment terms.

How this shortlist was selected

CoreAge Rx is number one because it is our featured commercial partner. That position is predetermined by our commercial relationship, and we may earn compensation through its links. Other entries illustrate relevant care and payment models; their order is not a ranking of medication quality, safety, or patient outcomes.

Compare the full two-month commitment, the nonpromotional renewal, and the exact proposed formulation. We used the provider documents linked beside each entry, checked September 21, 2026. We did not purchase treatment, test private accounts, audit every license, or measure response times. The product and current written quote for your own care still need confirmation. Read our review method.

01. CoreAge Rx — featured partner

The featured commercial alternative for comparing another self-pay offer. Confirm plan length and total upfront payment before placing its starting rate beside Alan’s two-month promotion.

The current sale page advertises semaglutide from $99 per month and tirzepatide from $149 per month, with no membership fee. Those are advertised starting figures, not a personalized checkout quote. The plan length and total amount due must be read alongside the monthly equivalent.

The sale page says CoreAge works with U.S. compounding pharmacies and describes 503A facilities. A category of pharmacy is not a substitute for the name, address, and state license of the pharmacy filling your own prescription. Request that information before deciding.

Continue with our CoreAge Rx review and pricing details.

02. Yucca Health

Useful when you want published monthly pricing alongside a longer prepayment option. Compare the actual chosen term rather than mixing the lowest figures from different plans.

Yucca lists semaglutide at $125 per month on a six-month plan totaling $750, or $146 month to month. Tirzepatide is listed at $225 per month on a six-month plan totaling $1,350, or $258 month to month.

The $125 headline is a prepaid-plan equivalent, not the monthly-plan charge. Keep the selected term, renewal price, and cancellation policy with the purchase summary.

Check the official Yucca Health program page for the current offer and conditions. Our Yucca Health alternatives comparison examines other care models.

03. GobyMeds

Publishes concrete three-month starter totals. That makes the initial commitment visible, while renewal price and starter eligibility remain questions to settle.

GobyMeds lists a three-month semaglutide starter bundle at $299 total and a tirzepatide starter bundle at $399 total. Its $99 and $133 monthly headlines describe those bundles; the page says the lowest figures can reflect multi-month or introductory offers.

Cancellation depends on whether the prescription has reached the pharmacy. A prepaid starter bundle is not a guarantee of the same renewal price, and HSA/FSA payment is not insurance coverage.

Check the official GobyMeds program page for the current offer and conditions.

04. LumiMeds

A no-membership-fee comparison with care and shipping described as included. Its headline still needs a complete selected-plan quote before a reliable cost comparison.

LumiMeds advertises compounded semaglutide from $89 and tirzepatide from $125 per month, with provider review, medication, and delivery included and no membership fee. The homepage does not by itself establish every offer term or the complete upfront charge.

Get the selected plan length and next charge before treating a starting figure as an ongoing monthly price. Its statement about no dose-related upcharge still needs to match the offered prescription and contract.

Check the official LumiMeds program page for the current offer and conditions.

05. Fifty 410

A comparison with separate semaglutide monthly pricing and tirzepatide package tiers. Confirm product and duration so that the comparison is like for like.

Fifty 410 lists a three-month compounded tirzepatide starter package at $399 total, displayed as $133 per month. The listed mid- and higher-dose packages are $499 and $549 total. Its semaglutide monthly option is $199. These are different products and package sizes.

Ask which package matches the proposed prescription and whether a returning patient qualifies for a starter offer. A three-month supply and monthly billing are separate arrangements.

Check the official Fifty 410 program page for the current offer and conditions. Our Fifty 410 alternatives comparison examines other care models.

06. Ro

An alternative pathway for discussing branded treatment and coverage assistance. It uses separate membership and medication billing rather than an all-in compounded-treatment promotion.

Ro lists $39 for the first Body membership month, then $149 on a month-to-month plan, or an advertised monthly equivalent as low as $74 with annual prepayment. The cost of the medication is excluded.

For an insured prescription, Ro describes sending it to a pharmacy; cash-pay routes can differ. Confirm the pharmacy and whether your prescribed product is a manufacturer-labeled medicine. Do not use an old compounded-pricing article to identify the product in a new Ro checkout.

Continue with our Ro review and pricing details.

The current Alan Health (Alan Meds) baseline

The Alan Health site, reached at alanmeds.com, displays compounded semaglutide from $158 per month for a two-month prepaid promotion. The page also contains other term-specific promotions; the selected product and full checkout charge control the comparison.

Alan describes online provider review, pharmacy fulfillment if prescribed, and ongoing clinician support. Its compounded-product disclosures state that these preparations are not FDA-approved.

Confirm the nonpromotional refill price, term, and full upfront amount. A buy-one-get-one offer should not be treated as a permanent month-to-month price or as evidence of a better formulation.

The details that decide this comparison

Ask what price applies when the introductory package ends. An average derived from a free promotional month is not a recurring monthly rate.

Identify whether the proposed product is an injection, an approved branded medicine, or another compounded formulation. Ingredient names alone do not settle that question.

Verify which clinician and pharmacy handle a refill or a treatment change. On-demand support should have a defined clinical contact route.

Keep the treatment distinction clear

An FDA-approved branded medicine and a compounded preparation have different regulatory status. Compounded drugs are not FDA-approved. Trials of an approved product do not prove that every compounded version has the same performance.

Ask the prescribing professional why the exact product is appropriate for you, and identify the dispensing pharmacy. A price, a website’s appearance, or a place in this list cannot establish personal suitability. Our guide to compounded drugs and FDA approval explains the distinction.

Before you make a change

Keep the dated promotional page and the checkout terms together. If the same site displays several campaign figures, ask which one applies to your product and term.

Do not let an unused promotional month determine a medication decision. If treatment is not suitable, ask the clinician about care and the administrative team about the applicable cancellation terms.

Sources & research notes

Checked September 21, 2026. Provider pages document the provider’s own statements; they do not independently establish treatment safety or results. This is desk research, not a product test or clinical review.

  1. CoreAge Rx: official treatment overviewProvider-published information · Checked September 21, 2026
  2. CoreAge Rx: current sale offerProvider-published information · Checked September 21, 2026
  3. CoreAge Rx: plan billing explainedProvider-published information · Checked September 21, 2026
  4. CoreAge Rx: contact and professional-entity disclosuresProvider-published information · Checked September 21, 2026
  5. CoreAge Rx: purchasing processProvider-published information · Checked September 21, 2026
  6. Yucca Health: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  7. GobyMeds: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  8. LumiMeds: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  9. Fifty 410: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  10. Weight Loss - Ro Body Membership | RoProvider-published information · Checked September 21, 2026
  11. Ro - Telehealth for ED, Hair loss, Skincare, Fertility and MoreProvider-published information · Checked September 21, 2026
  12. Alan Health (Alan Meds): official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  13. FDA: concerns with unapproved GLP-1 drugsRegulatory / public agency · Checked September 21, 2026
  14. FDA: risks of compounded drugsRegulatory / public agency · Checked September 21, 2026

Read our methodology · Commercial disclosure · Request a correction